Marcella Montico

Clinical Validity of Imatinib Therapeutic Drug Monitoring in a Real-World Italian Cohort of Gastrointestinal Stromal Tumors and the Role of Patients’ Sex

Sara Gagno, Angela Buonadonna, Eleonora Cecchin, Arianna Fumagalli et autres

it (code pays fourni par la source)

Inavolisib for PIK3CA-mutated advanced endometrial cancer: a multicentric, phase II, MITO END-4 trial

Anna Passarelli, Michele Bartoletti, Alberto Farolfi, Maria Lucia Iacovino et autres

it, my, us, ch (code pays fourni par la source)

DPYD and UGT1A1 Genotype‐Based Dosing for Fluoropyrimidines and Irinotecan Chemotherapy: Variant‐Specific Impact on Treatment Intensity and Toxicity

Martina Gambron, Elena Peruzzi, Samantha Perfler, Marcella Montico et autres

it (code pays fourni par la source)

Immunotherapy with anti-PD-1 or PD-L1 in advanced ovarian cancer: A meta-analysis of randomized trials

Riccardo Vida, Michele Bartoletti, Marcella Montico, Sandro Pignata et autres

it (code pays fourni par la source)

Impact of opioid-free general anesthesia with locoregional blocks during breast cancer surgery on systemic inflammatory response: results from a randomized controlled trial

Fabrizio Brescia, Andrea Favero, Ilenia Segatto, Samuele Massarut et autres

it, ua (code pays fourni par la source)

Immunotherapy with anti-PD-1 or PD-L1 in advanced ovarian cancer (OC): A meta-analysis of randomized trials.

Riccardo Vida, Michele Bartoletti, Marcella Montico, Monica Rizzetto et autres

it (code pays fourni par la source)

Radical hemithorax radiotherapy induces an increase in circulating PD-1+ T lymphocytes and in the soluble levels of PD-L1 in malignant pleural mesothelioma patients: a possible synergy with PD-1/PD-L1 targeting treatment?

Alberto Revelant, Francesca Gessoni, Marcella Montico, Raja Dhibi et autres

it (code pays fourni par la source)

Radical hemithorax radiotherapy induces an increase in circulating PD-1+ T lymphocytes and in the soluble levels of PD-L1 in Malignant Pleural Mesothelioma patients: a possible synergy with PD-1/PD-L1 targeting treatment?

Alberto Revelant, Francesca Gessoni, Marcella Montico, Raja Dhibi et autres

Imatinib and norimatinib therapeutic monitoring using dried blood spots: Analytical and clinical validation, and performance comparison of volumetric collection devices

Marco Orleni, Sara Gagno, Eleonora Cecchin, Marcella Montico et autres

ua, it (code pays fourni par la source)

Clinical Benefits and Utility of Pretherapeutic DPYD and UGT1A1 Testing in Gastrointestinal Cancer

Rossana Roncato, Alessia Bignucolo, Elena Peruzzi, Marcella Montico et autres

it, nl (code pays fourni par la source)

Real world clinical outcomes from targeted intraoperative radiotherapy (TARGIT-IORT) during lumpectomy for breast cancer: data from a large cohort at a national cancer institute

Lorenzo Vinante, Jayant S. Vaidya, Angela Caroli, Mario Mileto et autres

it, gb (code pays fourni par la source)

EP.12B.14 Platinum-Pemetrexed Chemotherapy and Lorlatinib Combination in Advanced ALK Positive NSCLC Progressing to Lorlatinib: A Case Series

Elisa Bertoli, Elisa De Carlo, Marcella Montico, Alessandro Del Conte et autres

ua, it (code pays fourni par la source)